ONTY

Oncothyreon Inc

A clinical-stage biopharmaceutical company that developed cancer therapies, including Stimuvax, a therapeutic vaccine designed to train the immune system to attack tumor cells. It began life as Biomira Inc. in Edmonton, Canada, before reincorporating in the United States and renaming itself Oncothyreon in 2007. The name blends Greek words for "tumor" and "shield," reflecting the company's aim to shield patients from cancer's effects.

No Schedule 13D or 13G filings recorded.